psychedelic research - Psychedelic Institute of Mental Health & Family Therapy

psychedelic research

Spotlight: Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics? (Garcia-Romeu, 2025)

The relative contribution of drug vs. psychological support remains to be determined, though preliminary data indicate the therapeutic relationship can impact treatment outcomes [12], and factors such as environment, personality, and mindset can influence subjective drug effects.

ketamine

Spotlight: A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings (McInnes, et al, 2025)

"In a large real-world sample of 8,136 PTSD patients (87 % with comorbid depression), Ketamine Intravenous Therapy (KIT) significantly reduced PTSD and depression symptoms."

ketamine

Spotlight "Prefrontal contribution to passive coping behaviour in chronic stress and treatment by fast-acting antidepressant" (Fong, et al, 2025)

"Persistent passive coping (p-coping) behaviour is a hallmark feature in major depression and is reversed by fast-acting antidepressants (such as ketamine)."

ketamine

Spotlight: Recent study finds ketamine described as having visual effects, outranking many serotonergic psychedelics and plant medicines

Ketamine was described with visual words more often than mushrooms and LSD according to a LLM analysis of Erowid data. DMT was the most described using visual words

michael demarco therapist

About the Psychedelic Institute of Mental Health & Family Therapy

Collaborative psychotherapy in support of medicines that may affect mental health, including ketamine

ketamine-assisted psychotherapy

Sublingual & Oral Ketamine Research: Efficacy, Dosage, and Treatment for Mental Health

Ongoing review of the literature related to safety and efficacy of ketamine and esketamine by mouth.